New Drug Application Submitted For Investigational Antibiotic Doripenem (Medical News Today)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for doripenem, an investigational carbapenem antibiotic for the treatment of complicated intra-abdominal and complicated urinary tract infections. [click link for full article]

CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients with Metastatic Breast Cancer (Business Wire via Yahoo! Finance)
HUNTINGDON VALLEY, Pa.----Immunicon Corporation announced today that Veridex, LLC, a Johnson & Johnson company, received FDA clearance for the CellSearch Circulating Tumor Cell Kit as an aid in the monitoring of patients with metastatic breast cancer.